Trial of AD036 in Obstructive Sleep Apnea
Completed · Phase 2 · Has a placebo group
Conditions studied: Obstructive Sleep Apnea
In brief
This is a randomized, double blind, placebo-controlled, repeat-dose, parallel arm, outpatient and inpatient phase 2 clinical study to examine the efficacy and safety of three dose levels of AD036 versus placebo in patients with obstructive sleep apnea.
Key facts
- Study ID
- NCT03845023
- Run by
- Apnimed
- People needed
- 140
- Starts
- 2019-03-07
- Expected to finish
- 2019-10-23
- Last updated by the study team
- 2023-01-17
Who can join
Age: 25 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Pulmonary Associates — Glendale, Arizona, United States
- Preferred Research Partners, Inc. — Little Rock, Arkansas, United States
- Stanford Sleep Medicine — Redwood City, California, United States
- SDS Clinical Trials, Inc. — Santa Ana, California, United States
- Santa Monica Clinical Trials — Santa Monica, California, United States
- Northwestern University — Chicago, Illinois, United States
- Norton Clinical Research Group — Louisville, Kentucky, United States
- The Center for Sleep and Wake Disorders — Chevy Chase, Maryland, United States
- Sleep Medicine & Research Center, St. Luke's Hospital — Chesterfield, Missouri, United States
- Clinilabs Drug Development Corporation — New York, New York, United States
- CTI Clinical Research Center — Cincinnati, Ohio, United States
- Sleep Therapy & Research Center — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.